Moreover, in vitro amplification of patient-derived tau seeds from AD, CBD, and PSP with 2N4R recombinant tau was performed, which faithfully retained strain-dependent pathogenic characteristics when injected into 6hTau mice. This evidence concerns the gene MAPT and Alzheimer disease.